In order to have a better understanding of the functional relationship of mutant Kras and mutant Hras with favorable FL118 efficacy, we first determined whether there is a differential ROS induction by FL118 treatment in the three bladder cancer cells (HT1376, T24, UMUC-3). Here, HRAS is linked to urinary bladder carcinoma.